MURAE ORGANISOR LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.48 INR | -1.99% |
|
-7.50% | +28.70% |
| 04-24 | Murae Organisor Limited Announces Board Appointments | CI |
| 04-04 | Murae Organisor Limited Appoints Sangita Rajpurohit as Company Secretary and Compliance Officer | CI |
| Sales 2022 | 210M 2.52M 201M | Sales 2023 | 141M 1.69M 134M | Capitalization | 130M 1.56M 124M |
|---|---|---|---|---|---|
| Net income 2022 | 22M 264K 20.98M | Net income 2023 | 19M 228K 18.12M | EV / Sales 2022 | 2.05 x |
| Net Debt 2022 | 96.79M 1.16M 92.32M | Net Debt 2023 | 87.15M 1.04M 83.12M | EV / Sales 2023 | 1.54 x |
| P/E ratio 2022 |
15
x | P/E ratio 2023 |
6.57
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 95.13% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.99% | ||
| 1 week | -7.50% | ||
| Current month | -5.73% | ||
| 1 month | -17.78% | ||
| 3 months | -47.52% | ||
| 6 months | +28.70% | ||
| Current year | +28.70% |
1 week
1.48
1.54
1 month
1.481.89
Current year
1.233.10
1 year
0.903.10
3 years
0.9026.40
5 years
0.9026.40
10 years
0.9026.40
| Members of the board | Title | Age | Since |
|---|---|---|---|
Vijaykumar Patel
CEO | Chief Executive Officer | - | 07/08/23 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/05/24 | 1.48 | -1.99% | 616,117 |
| 03/05/24 | 1.51 | -1.95% | 405,693 |
| 02/05/24 | 1.54 | -1.91% | 571,560 |
| 30/04/24 | 1.57 | -1.88% | 192,589 |
Delayed Quote Bombay S.E., May 06, 2024 at 11:00 am
More quotes
Murae Organisor Limited, formerly Earum Pharmaceuticals Limited, is an India-based pharmaceutical company. The Company is primarily engaged in marketing, trading and distribution of a range of pharmaceutical formulation products, such as anti-biotic drugs, anti-malarial drugs, anti-allergic & anti-cold drugs, analgesic/ anti-pyretic & anti-inflammatory drugs, dermatology products, cerebral activator drugs, neurological drugs, gastrointestinal drugs, steroids, gynecology drugs, calcium, multivitamins, antioxidants and injections. It offers a range of pharmaceutical formulation products, of which around 120 products are marketed by it under its own brand name. It also deals in the trading of active pharmaceutical ingredients (APIâs). Its products include HYGNEX+, HYGNEX+ Spray, EROLON and HYGNEX. It carries its business operations in Indian States, such as Gujarat, Maharashtra, Chhattisgarh, Uttar Pradesh, Mizoram, Andhra Pradesh, Rajasthan and others.
Sector
Pharmaceuticals
Calendar
01/07/2024
- Q4 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +28.70% | 4.47M | |
| +31.52% | 662B | |
| +21.96% | 546B | |
| -5.21% | 359B | |
| +17.02% | 323B | |
| +5.01% | 289B | |
| +13.68% | 234B | |
| +3.81% | 198B | |
| -10.63% | 194B | |
| +3.98% | 167B |
- Stock Market
- Equities
- 542724 Stock
